Inflammation following acute myocardial infarction: Multiple players, dynamic roles, and novel therapeutic opportunities

By S. Ong, S. Hernandez-Resendiz, G. Crespo-Avilan, R. Mukhametshina, Xiu-Yi Kwek, H. Cabrera-Fuentes, D. Hausenloy. Pharmacology and Therapeutics, 2018

802 citations recorded by the source corpus.

ABSTRACT Acute myocardial infarction (AMI) and the heart failure that often follows, are major causes of death and disability worldwide. As such, new therapies are required to limit myocardial infarct (MI) size, prevent adverse left ventricular (LV) remodeling, and reduce the onset of heart failure following AMI. The inflammatory response to AMI, plays a critical role in determining MI size, and a persistent pro‐inflammatory reaction can contribute to adverse post‐MI LV remodeling, making inflammation an important therapeutic target for improving outcomes following AMI. In this article, we provide an overview of the multiple players (and their dynamic roles) involved in the complex inflammatory response to AMI and subsequent LV remodeling, and highlight future opportunities for targeting inflammation as a therapeutic strategy for limiting MI size, preventing adverse LV remodeling, and reducing heart failure in AMI patients.

Subfields: Cardiology and Cardiovascular Medicine, Molecular Biology, Pathology and Forensic Medicine

View Paper: https://www.semanticscholar.org/paper/9238ae82bbf66334dba28e75cd64e6c4676e4570

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

  1. Jinxuan Zhao
  2. Xueling Li
  3. Ling Gao
  4. Xuan Sun
  5. Fu Chen
  6. Jun Xie
  7. Biao Xu
  8. Jiaxin Hu

Citations in the corpus